Clinical Trial Update: Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for lifitegrast 5% ophthalmic solution addressing contact lens discomfort and dryness conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contact Lens Discomfort
• Contact Lens Dryness
• Contact Lens Intolerance

Drugs mentioned

• lifitegrast 5% ophthalmic solution (lifitegrast)

Snippet

Sponsor: EV Clinical Trials | Conditions: Contact Lens, Contact Lens Discomfort | Phase 4 | Status: COMPLETED